Basic MaterialsChemicals
  • Price (CHF)3,688.00
  • Today's Change13.00 / 0.35%
  • Shares traded21.16k
  • 1 Year change34.40%
  • Beta0.7799
Data delayed at least 15 minutes, as of Jul 14 2020 16:31 BST.
More ▼

Profile data is unavailable for this security.

About the company

Givaudan SA is a Switzerland-based company engaged in the fragrance and flavor industry. The Company has two business divisions: Fragrances and Flavors. The Fragrances segment comprises the manufacture and sale of fragrances through four business units: Fine Fragrances, comprising fragrances; Consumer Products, comprising personal care, hair and skin care, household care, and oral care; Fragrance Ingredients; and Cosmetics Activities, comprising cosmetics. The Flavors business division comprises the manufacture and sale of flavors into four business units: Beverages, comprising flavors for soft drinks, fruit juices and instant beverages; Dairy, comprising ice cream, yoghurt, desserts and yellow fats; Savory, covering soups and sauces; and Confectionery. The Company also engages in research and development activities into perfumery raw materials, both synthetic and natural. It operates through Induchem Holding AG and Activ International, among others.

  • Revenue in CHF (TTM)6.20bn
  • Net income in CHF702.00m
  • Incorporated1929
  • Employees14.97k
  • Location
    Givaudan SAChemin de la Parfumerie 5VERNIER 1214SwitzerlandCHE
  • Phone+41 227809111
  • Fax+41 227809150
  • Websitehttps://www.givaudan.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GIVN:VTX since
Indena SPA-Cosmetics BusinessDeal completed26 Nov 201926 Nov 2019Deal completed26.09%--
Ungerer & CoAnnounced08 Nov 201908 Nov 2019Announced28.41%--
Fragrance Oils (International) LtdDeal completed21 Aug 201921 Aug 2019Deal completed42.95%--
drom fragrances GmbH & Co KGDeal completed24 Jul 201924 Jul 2019Deal completed39.64%--
Data delayed at least 15 minutes, as of Jul 14 2020 16:31 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Arkema SA9.22bn451.99m7.47bn20.50k16.461.236.410.80955.525.52112.5473.860.78175.866.28419,905.404.375.455.346.7521.2221.565.596.151.576.410.347633.05-0.88487.98-27.1524.076.343.53
Brenntag AG13.76bn509.40m8.36bn17.40k16.352.1810.030.60793.093.0983.4723.171.498.436.45734,370.005.565.527.577.5621.7721.503.733.491.279.020.416340.
Yara International ASA11.92bn363.25m9.32bn16.03k25.671.247.520.781513.3013.30438.03276.430.76443.937.007,424,902.002.293.982.975.0028.0625.782.994.861.063.100.3366108.71-0.5415-3.13276.73-13.11-0.8641-3.69
Umicore SA18.73bn308.24m11.70bn14.13k37.264.1218.000.62471.191.1972.2810.772.676.8813.561,237,619.004.584.887.418.126.127.361.711.910.65426.710.39242.8727.4716.56-9.2113.0124.87-6.89
Evonik Industries AG13.99bn727.25m12.16bn32.77k16.711.247.410.86921.464.2928.0519.620.59424.627.70402,954.703.174.173.995.0527.8531.015.345.961.0112.710.349468.57-1.200.2949.775.47-4.282.83
Novozymes A/S2.11bn470.89m13.17bn6.07k34.4810.3720.486.2411.4811.4851.4838.170.71932.424.962,516,544.0016.0416.3721.4421.1855.7357.4822.3021.520.983838.190.347242.19-0.11122.90-2.234.546.6411.84
Chr Hansen Holding A/S1.27bn271.34m13.44bn3.42k49.3714.9138.2310.5714.3514.3567.2047.520.55953.006.622,582,760.0011.9512.2814.8614.6955.6954.2221.3520.450.620625.850.539381.535.808.959.6413.6117.3228.68
Akzo Nobel NV9.80bn607.29m17.20bn33.50k30.202.4616.491.762.762.8544.9033.840.62814.253.93270,680.504.173.915.545.6143.4842.986.656.101.0530.890.258477.820.2161-8.2929.25-0.4202-18.303.10
Koninklijke DSM N.V.9.65bn776.52m24.87bn21.87k30.992.9217.742.584.134.1151.3143.840.6413--4.97406,376.804.834.526.025.75--34.187.546.791.3013.910.275939.64-2.775.03-30.0818.74-0.37037.78
Sika AG8.11bn751.90m27.23bn25.14k40.1410.1724.963.364.784.7851.6618.890.99334.525.87322,548.809.2910.5711.6313.4853.5754.009.359.571.4419.400.580443.7014.457.8010.1011.364.7213.89
Givaudan S.A.6.20bn702.00m34.05bn14.97k48.799.3432.255.4975.5975.59667.93394.880.63063.274.74414,389.807.148.878.5310.6340.7943.6011.3212.981.1412.840.530379.8412.237.095.884.518.384.40
Henkel AG & Co KGaA21.54bn2.23bn37.17bn52.45k17.721.9912.141.734.804.8046.3242.650.65994.955.73383,489.006.908.219.7311.4246.2547.2210.4611.390.815343.310.175434.271.084.13-9.785.074.987.15
L'Air Liqud Soct Ae pr l'Edeetl'EndsPsGe23.48bn2.40bn68.94bn67.20k28.753.4114.382.944.734.7346.2639.890.51195.458.81326,192.005.465.536.636.7762.8062.2210.6610.880.651710.490.430953.554.337.376.066.136.755.64
Data as of Jul 14 2020. Currency figures normalised to Givaudan SA's reporting currency: Swiss Franc CHF

Institutional shareholders

29.90%Per cent of shares held by top holders
HolderShares% Held
Bill & Melinda Gates Foundation Trust (Investment Management)as of 31 Dec 20191.28m13.86%
MFS International (UK) Ltd.as of 25 Mar 2020461.65k5.00%
The Vanguard Group, Inc.as of 31 May 2020277.49k3.01%
UBS Asset Management Switzerland AGas of 07 Jul 2020174.50k1.89%
BlackRock Fund Advisorsas of 09 Jul 2020168.35k1.82%
Credit Suisse Asset Management (Schweiz) AGas of 30 Jun 2020120.00k1.30%
Norges Bank Investment Managementas of 31 Dec 2019101.48k1.10%
BlackRock Advisors (UK) Ltd.as of 09 Jul 202070.24k0.76%
Z�rcher Kantonalbank (Investment Management)as of 29 May 202054.10k0.59%
Capital Research & Management Co. (World Investors)as of 31 Mar 202052.98k0.57%
More ▼
Data from 31 Dec 2019 - 13 Jul 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.